Oxazolidinones

Oxazolidinones, the class exemplified by linezolid and tedizolid, are fully synthetic antibiotics that bind the 50S ribosomal subunit and interfere with the formation of the initiation complex, blocking protein synthesis at its earliest stage. They are active primarily against Gram-positive bacteria, including resistant organisms such as MRSA and vancomycin-resistant enterococci.

Definition

Oxazolidinones are synthetic antibiotics that bind the 50S subunit at the peptidyl transferase centre, on the A-site side, and prevent productive assembly of the functional initiation complex, thereby inhibiting bacterial protein synthesis chiefly against Gram-positive organisms.

Scope

This topic covers the synthetic origin of the class, the ribosomal binding site at the peptidyl transferase centre, the unusual early-step mechanism, the Gram-positive spectrum, and the basis of selectivity and resistance. It is a pharmacological reference entry and does not provide prescribing or dosing guidance.

Core questions

• At what step of translation do oxazolidinones act, and how does this differ from other 50S-binding drugs?
• Where on the 50S subunit do they bind?
• Why is the oxazolidinone spectrum essentially Gram-positive?
• What is the significance of a fully synthetic class with no natural cross-resistance?

Key concepts

• Fully synthetic antibiotic class
• 50S binding at the peptidyl transferase centre A-site
• Inhibition of initiation-complex formation
• Gram-positive spectrum (including MRSA, VRE)
• Lack of pre-existing cross-resistance at introduction
• 23S rRNA mutation and cfr-mediated resistance

Mechanisms

Oxazolidinones bind the large (50S) ribosomal subunit at the peptidyl transferase centre, on the side of the A site, within the same functional region targeted by several other 50S-active drugs. Rather than blocking elongation of an already-started chain, they interfere with the formation of a productive initiation complex, acting at an unusually early point in translation; this distinct mechanism is one reason the class showed no cross-resistance with previously used antibiotics when it was introduced. The drugs are fully synthetic, so unlike most antibiotic classes they were not derived from natural products and bacteria had not been pre-exposed to related compounds. Resistance, where it emerges, involves mutations in the 23S ribosomal RNA at the binding site and acquisition of the cfr gene, whose product methylates the rRNA and reduces drug binding.

Clinical relevance

Oxazolidinones provide an option against serious Gram-positive infections, including methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and their distinct early-step mechanism and synthetic origin explain the absence of pre-existing cross-resistance at the time of introduction. This entry describes the pharmacological basis of the class for reference and is not a guide to drug selection, dosing, or monitoring.

Evidence & guidelines

The antibacterial spectrum and mechanism of the prototype linezolid are summarized in in vitro mechanistic reviews, and the binding location at the peptidyl transferase centre is consistent with crystal structures of 50S-antibiotic complexes; class pharmacology is compiled in standard references.

History

The oxazolidinone scaffold was first explored as an antibacterial in the late 1980s, and linezolid became the first member of the class approved for clinical use around 2000, the first genuinely new antibiotic class in decades. Because the agents are synthetic and act at an unusual early step of translation, they entered practice without pre-existing cross-resistance, though target-site mutations and the transferable cfr methyltransferase later emerged. A second-generation agent, tedizolid, followed.

Key figures

• David M. Livermore
• Ada E. Yonath
• Alexander Mankin

Seminal works

• livermore-2003
• schlunzen-2001

Frequently asked questions

Why did oxazolidinones have no cross-resistance with older antibiotics when they were introduced?

They are a fully synthetic class with a distinct binding mode and act at an early, initiation stage of translation rather than the elongation steps targeted by most other ribosomal antibiotics, so resistance mechanisms selected by earlier drugs did not protect bacteria against them.

Why are oxazolidinones used mainly for Gram-positive infections?

Their antibacterial activity is concentrated against Gram-positive organisms, including resistant strains such as MRSA and vancomycin-resistant enterococci, which defines the niche in which the class is principally employed.